WithdrawnNot Applicable

A Pilot Study to Explore the Role of Gut Flora in Metastatic Mesothelioma

Stopped: Company focus shifted

United States0Started 2020-03-02

Plain-language summary

This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records.

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Signed informed consent, demonstrating that the patient understands the procedures required for the study and the purpose of the study
✓. Male or female of all ages. (interest is given to children who present with autism or Crohn's and whose parents wish to analyze their children's gut flora. Also of interest analysis of development of the child's microbiome. In the case of autism, the younger the child, the better to correct the neurological problems if an association is found between autism and the microbiome)
✓. Diagnosis of metastatic mesothelioma through biopsy and/or advanced imaging

✕. Refusal to sign informed consent form
✕. History of bariatric surgery, total colectomy with ileorectal anastomosis or proctocolectomy.
✕. Postoperative stoma, ostomy, or ileoanal pouch
✕. Participation in any experimental drug protocol within the past 12 weeks
✕. Treatment with total parenteral nutrition

Correlation of Microbiome to Disease via Relative Abundance Found in Microbiome Sequencing

Timeframe: Three years

NCT IDNCT04214015

SponsorProgenaBiome

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2030-03